Ansah 2003.

Methods	Quasi‐randomized controlled trial Generation of allocation sequence: alternate allocation Allocation concealment: no information provided Blinding of outcome assessor: none Completeness of outcome data: 99%
Participants	Participants: 299 analysed (155 intervention; 144 control); 301 initially recruited Inclusion criteria: aged 0 to 5 years; brought to 1 of 2 clinics with malaria Exclusion criteria: none given, but 2 participants excluded on developing severe malaria Mean age: not stated Age range: not stated Male to female ratio: not stated Education: not stated
Interventions	See Appendix 2 for details
Outcomes	Treatment adherence: number of participants following the prescribers' exact instructions in terms of dosage (spoon size for syrup not taken into account), frequency of daily administration, and duration of treatment; measured by participant interview Caregivers' assessment of wellness at day 4 Vomiting of tablets Not included in review: Packaging acceptability and preference Financial and economic costs
Notes	Location: Cape Coast, Ghana Health facilities: 2 public health centres Endemicity: highly endemic malaria Antimalarial drug resistance: not stated Malaria diagnosis: clinical (Plasmodium falciparum causes most morbidity and mortality in this area)